Raymond James & Associates’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.12M | Sell |
19,433
-888
| -4% | -$188K | ﹤0.01% | 1779 |
|
|
2024
Q2 | $5.69M | Buy |
20,321
+37
| +0.2% | +$10.4K | ﹤0.01% | 1493 |
|
|
2024
Q1 | $5.42M | Buy |
20,284
+554
| +3% | +$148K | ﹤0.01% | 1522 |
|
|
2023
Q4 | $4.57M | Sell |
19,730
-721
| -4% | -$167K | ﹤0.01% | 1598 |
|
|
2023
Q3 | $2.99M | Buy |
20,451
+5,295
| +35% | +$773K | ﹤0.01% | 1774 |
|
|
2023
Q2 | $3.5M | Buy |
+15,156
| New | +$3.5M | ﹤0.01% | 1714 |
|
|
2014
Q1 | – | Sell |
-2,588
| Closed | -$475K | – | 2100 |
|
|
2013
Q4 | $475K | Buy |
+2,588
| New | +$475K | ﹤0.01% | 1686 |
|